Prostatype Genomics AB (publ) (STO:PROGEN)

Prostatype Genomics AB Statistics

Total Valuation

STO:PROGEN has a market cap or net worth of SEK 66.88 million. The enterprise value is 57.82 million.

Market Cap	66.88M
Enterprise Value	57.82M

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:PROGEN has 59.19 million shares outstanding.

Current Share Class	59.19M
Shares Outstanding	59.19M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+669.75%
Owned by Insiders (%)	4.70%
Owned by Institutions (%)	n/a
Float	56.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	112.60
PB Ratio	2.52
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.30
EV / Sales	97.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.40

Financial Position

The company has a current ratio of 0.44

Current Ratio	0.44
Quick Ratio	0.43
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-24.11

Financial Efficiency

Return on equity (ROE) is -148.35% and return on invested capital (ROIC) is -81.03%.

Return on Equity (ROE)	-148.35%
Return on Assets (ROA)	-52.43%
Return on Invested Capital (ROIC)	-81.03%
Return on Capital Employed (ROCE)	-146.78%
Weighted Average Cost of Capital (WACC)	16.10%
Revenue Per Employee	99,000
Profits Per Employee	-7.42M
Employee Count	6
Asset Turnover	0.01
Inventory Turnover	240.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.27% in the last 52 weeks. The beta is 2.16, so STO:PROGEN's price volatility has been higher than the market average.

Beta (5Y)	2.16
52-Week Price Change	-78.27%
50-Day Moving Average	1.13
200-Day Moving Average	0.90
Relative Strength Index (RSI)	47.70
Average Volume (20 Days)	526,588

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:PROGEN had revenue of SEK 594,000 and -44.50 million in losses. Loss per share was -1.32.

Revenue	594,000
Gross Profit	-20.20M
Operating Income	-38.94M
Pretax Income	-44.50M
Net Income	-44.50M
EBITDA	-36.75M
EBIT	-38.94M
Loss Per Share	-1.32

Balance Sheet

The company has 9.07 million in cash and n/a in debt, with a net cash position of 9.07 million or 0.15 per share.

Cash & Cash Equivalents	9.07M
Total Debt	n/a
Net Cash	9.07M
Net Cash Per Share	0.15
Equity (Book Value)	26.53M
Book Value Per Share	0.45
Working Capital	-13.69M

Cash Flow

In the last 12 months, operating cash flow was -23.80 million and capital expenditures -258,000, giving a free cash flow of -24.06 million.

Operating Cash Flow	-23.80M
Capital Expenditures	-258,000
Free Cash Flow	-24.06M
FCF Per Share	-0.41

Margins

Gross Margin	n/a
Operating Margin	-6,555.22%
Pretax Margin	-7,492.09%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

STO:PROGEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-66.54%
FCF Yield	-35.97%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 31, 2024. It was a reverse split with a ratio of 0.001.

Last Split Date	Oct 31, 2024
Split Type	Reverse
Split Ratio	0.001

Scores

Altman Z-Score	n/a
Piotroski F-Score	1